http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2696473-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 2008-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9dae6e3380ebe5d8fba98b1c7cd6ddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2062111a4ad8d2b08f36bc84480b5ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88141e86eb02e92e1f845de69c2fb89a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff17e53ca57e5b0e6fec4ef35ffabe9d
publicationDate 2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2696473-A1
titleOfInvention Small molecule inhibitors of lck sh2 domain binding
abstract The present invention provides, materials and methods for modulating an immune response. The materials and methods may be used to treat diseases associated with an aberrant immune response. In some embodiments, materials and methods of the invention may be used to treat autoimmune diseases, for example, rheumatoid arthritis.
priorityDate 2007-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9838899
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID338578
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID338578
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1762044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410252431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453161383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918537
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451814683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450207671
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2M4I4
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID75038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9929
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1762044
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID75038
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9929
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13385

Total number of triples: 54.